Showing results (171-180 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|November 18, 2015
Antidepressant efficacy and side-effect burden: a quick guide for cliniciansDaniel Santarsieri, Thomas L SchwartzDrugs in Context|September 1, 2015
Effect of variations in treatment regimen and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndromePavel Gershkovich, Kishor M Wasan, Charles Ribeyre, et al.Drugs in Context|January 20, 2015
Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agentsEva M VivianDrugs in Context|January 20, 2015
The cost of biologics for psoriasis is increasingJudy Cheng, Steven R FeldmanDrugs in Context|July 28, 2015
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyondLalita Prasad-Reddy, Diana IsaacsDrugs in Context|December 12, 2018
Dismissing the fallacies of childhood eczema management: case scenarios and an overview of best practicesKam Lun Hon, Kin Fon Leong, Theresa Nh Leung, et al.Drugs in Context|June 28, 2021
Bimekizumab: the new drug in the biologics armamentarium for psoriasisEgídio Freitas, Tiago TorresDrugs in Context|June 9, 2021
Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life settingMartina Burlando, Riccardo Castelli, Emanuele Cozzani, et al.Drugs in Context|March 12, 2020
Tumor lysis syndrome in childhood malignanciesWing Lum Cheung, Kam Lun Hon, Cheuk Man Fung, et al.Drugs in Context|December 5, 2019
Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literaturePietro Sollena, Maria Mannino, Francesco Tassone, et al.Pageof 56